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Escherichia coli of sequence type 
3835 carrying blaNDM-1, blaCTX-M-15, 
blaCMY-42 and blaSHV-12
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New Delhi metallo-β-lactamase (NDM) represents a serious challenge for treatment and public 
health. A carbapenem-resistant Escherichia coli clinical strain WCHEC13-8 was subjected to 
antimicrobial susceptibility tests, whole genome sequencing and conjugation experiments. It was 
resistant to imipenem (MIC, >256 μg/ml) and meropenem (MIC, 128 μg/ml) and belonged to ST3835. 
blaNDM-1 was the only carbapenemase gene detected. Strain WCHEC13-8 also had a plasmid-borne 
AmpC gene (blaCMY-42) and two extended-spectrum β-lactamase genes (blaCTX-M-15 and blaSHV-12). 
blaNDM-1 and blaSHV-12 were carried by a 54-kb IncX3 self-transmissible plasmid, which is identical 
to plasmid pNDM-HF727 from Enterobacter cloacae. blaCMY-42 was carried by a 64-kb IncI1 plasmid 
and blaCTX-M-15 was located on a 141-kb plasmid with multiple F replicons (replicon type: F36:A4:B1). 
blaCMY-42 was in a complicated context and the mobilisation of blaCMY-42 was due to the transposition 
of ISEcp1 by misidentifying its right-end boundary. Genetic context of blaNDM-1 in strain WCHEC13-8 
was closely related to those on IncX3 plasmids in various Enterobacteriaceae species in China. In 
conclusion, a multidrug-resistant ST3835 E. coli clinical strain carrying blaNDM-1, blaCTX-M-15, blaCMY-42 
and blaSHV-12 was identified. IncX3 plasmids may be making a significant contribution to the 
dissemination of blaNDM among Enterobacteriaceae in China.
Carbapenems have long served as reliable and potent agents against Gram-negative bacilli. However, a 
variety of enzymes produced by bacteria are able to hydrolyse carbapenems, termed carbapenemases. New 
Delhi metallo-β -lactamase (NDM) is a type of carbapenemase and confers resistance to all β -lactams 
except monobactams1. NDM was first found in a Klebsiella pneumoniae isolate in 20082 and since then 
bacterial isolates producing NDM have been identified worldwide, representing a serious challenge for 
treatment, infection control and public health. In addition to India, China is a common place from 
which NDM-producing isolates are identified. In China, NDM was initially seen in Acinetobacter spp3. 
but NDM-producing Enterobacteriaceae have been increasingly reported4. Among carbapenem-resistant 
Enterobacteriaceae in China, K. pneumoniae is the most common species with 10% of 12,121 K. pneumo-
niae clinical isolates collected from 16 major teaching hospitals in 2013 resistant to imipenem5. In con-
trast, carbapenem resistance is relatively uncommon in Escherichia coli in China and only 1% of 16,794 
E. coli clinical isolates from the 16 hospitals in 2013 were resistant to imipenem5. During routine clinical 
duties, a carbapenem-resistant E. coli clinical isolate was encountered. This strain was then characterised 
and is reported here.
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Results and Discussion
Clinical strain WCHEC13-8 was recovered on November 2012. This strain was identified as E. coli 
and was resistant to imipenem (Minimum inhibitory concentration [MICs], > 256 μ g/ml), meropenem 
(MIC, 128 μ g/ml), ceftazidime (MIC, > 256 μ g/ml), ciprofloxacin (MIC, 256 μ g/ml) but was interme-
diate to amikacin (MIC, 32 μ g/ml) determined by the microdilution method. It was also resistant to 
ampicillin-sulbactam, aztreonam, cefazolin, cefepime, cefotaxime, cefoxitin, ceftriaxone, gentamicin, 
piperacillin-tazobactam, tobramycin and trimethoprim-sulphamethoxazole determined by Vitek II. 
blaNDM was the only carbapenemase-encoding gene that was detected and sequencing the complete cod-
ing sequence of the gene revealed that it was blaNDM-1.
Strain WCHEC13-8 was subjected to whole genome sequencing on the Illumina HiSeq platform. A 
total of 7,149,960 reads and 643,496,400 bases were obtained from the genome sequencing with a 49.8% 
GC content. Reads were assembled to 268 contigs that were ≥ 500 bp in length (N50 metric, 118,912 bp) 
and contained 5,145,308 bp nucleotides. To identify whether strain WCHEC13-8 had any new genes 
or not, its genome sequence was compared to other E. coli genome sequences including 83 complete 
and 2,159 draft genomes available in GenBank. Despite comparing with such a large number of E. coli 
genomes, the strain still had three unique genes that were located on contigs belonging to the chromo-
some. Two of the three genes were clustered together and resided in the centre of a 149-kb large contig, 
which was part of the chromosome as it shows significant identity (74% coverage and 97% identity) with 
the chromosome of E. coli strain E2348/69 (GenBank accession number FM18568) identified using the 
BLAST program. The two novel genes encoded hypothetical proteins with 420 and 346 amino acids, 
respectively. Unfortunately, the function of the two hypothetical proteins were not able to be predicted 
using both Protein BLAST and InterProScan programs. The remaining unique gene was 2,976 bp on a 
small 3,322 bp contig and contained both an endonuclease/exonuclease/phosphatase and a reverse tran-
scriptase domain identified using the InterProScan program.
Strain WCHEC13-8 belonged to the phylogenetic group A and a new Sequence type (ST), ST3835 
(adk-fumC-gyrB-icd-mdh-purA-recA allele numbers, 10-4-4-411-8-13-73). Multiple ST3835 isolates have 
been found in Korea in 2013, which is later than strain WCHEC13-8 (http://mlst.warwick.ac.uk/mlst/
dbs/Ecoli). ST3835 has a single allele different from ST1284 (10-4-4-8-8-13-73) and ST3835 E. coli has 
been recovered from a human in Spain and from a dog in Germany (http://mlst.warwick.ac.uk/mlst/dbs/
Ecoli). ST3835 belongs to the ST10 complex. Besides ST3835, STs belonging to the ST10 complex (ST40, 
ST167, ST205, ST744 and ST1237), ST88 complex (ST224 and ST410), ST101 complex (ST101) or ST361 
complex (ST361) have been found to carry blaNDM-1 in China4,6–9. The diversity of clonal background of 
E. coli carrying blaNDM-1 suggests that the dissemination of blaNDM-1 in China was unlikely to be mainly 
mediated by a particular strain.
In addition to blaNDM-1, strain WCHEC13-8 had other resistance genes including blaCTX-M-15 (an 
extended-spectrum β -lactamase [ESBL] which is globally distributed), blaSHV-12 (an ESBL gene), blaCMY-42 
(a plasmid-borne AmpC cephalosporinase gene), blaOXA-1 (a non-ESBL oxacillinase gene), blaampC  
(a chromosome-based AmpC gene), aac(6′)-Ib-cr (encoding an aminoglycoside acetyltransferase with 
low-level activity against fluoroquinolones), aac(3)-II (encoding an aminoglycoside acetyltransferase), 
mph (encoding macrolide 2′ -phosphotransferase I) and tetB (conferring resistance to tetracycline). Of 
note, CMY-42, the AmpC enzyme encoded by blaCMY-42, differs from CMY-2 by a single amino acid sub-
stitution, i.e. Ser for Val at Ambler’s position 21110. The co-existence of blaNDM-1, blaCMY-42, blaCTX-M-15 and 
blaSHV-12, all of which encode a β -lactamase with the ability to hydrolyse broad-spectrum cephalosporins, 
in a single isolate has not been reported before. The co-presence of blaNDM-1, blaCMY-42 and blaCTX-M-15 has 
been found in an E. coli of ST101 from a two-year-old child who had recently travelled to India11, while 
two E. coli isolates of ST167 in China have been found carrying blaNDM-1, blaCMY-42 and blaCTX-M-146. In 
addition, blaCMY-42 has also been found in two E. coli isolates from a river in India (GenBank accession 
numbers KJ661335 and KJ661336) and one from a surgical wound at a university hospital in Germany10, 
but STs of the three E. coli isolates have not been reported. Of note, a report from Egypt also claimed that 
blaCMY-42 has been detected in 8 E. coli isolates12, but the gene detected was 99% similar to blaCMY-42 and 
the amino acid sequence of CMY was not available for analysis. Therefore, It remains unclear whether 
these Egyptian isolates carried blaCMY-42 or another variant.
Strain WCHEC13-8 had three plasmids, which were approximately 50, 60 and 140 kb in size, as 
revealed by S1 nuclease pulse-field gel electrophoresis (S1-PFGE). The three plasmids were completely 
circularised using PCR and Sanger sequencing. blaNDM-1 and blaSHV-12 were carried by a 54-kb plasmid, 
assigned pNDM1_EC8 here, of the IncX3 group. blaCMY-42 was located on a 64-kb IncI1 plasmid, assigned 
pCMY42_EC8 here, while blaCTX-M-15 was carried by a 141-kb IncF plasmid, assigned pCTXM15_EC8.
pCTXM15_EC8 contained multiple F replicons including one FIA, one FIB and two FII replicons. 
Based on the replicon sequence typing (RST) for IncF plasmids13, the replicon types of pCTXM15_EC8 
were F36:A4:B1 (FII 36, FIA 4 and FIB 1) with both FII replicons belonging to the same type. The 
F36:A4:B1 type has also been seen in plasmid p6409-151.583 kb (GenBank accession number CP010372), 
which was recovered from an E. coli strain in Colombia. However, p6409-151.583 kb has an additional 
F31 type FII replicon and does not carry blaCTX-M. Furthermore, the link between pCTXM15_EC8 and 
p6409-151.583 kb could not be established and the origin of pCTXM15_EC8 remains unknown.
pCMY42_EC8 harboured four of the five loci used for the IncI1 plasmid MLST scheme14. The four 
loci and their allele numbers were repI1 (IncI1 replicon) 4, ardA (alleviation of restriction of DNA) 5, 
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trbA (a gene essential for conjugative transfer) 15 and pilL (a pili gene) 3. The sogS (suppressor of dnaG 
mutation) locus was absent from pCMY42_EC8 and therefore no ST could be assigned. Nonetheless, 
pCMY42_EC8 was closely related to ST55 (repI1-ardA-trbA-sogS-pilL alleles 4-5-15-11-3) and ST141 
(4-5-15-4-3). Both STs comprise IncI1 plasmids carrying blaCMY-42 found in Taiwan (pubmlst.org/
plasmid).
The genetic context of blaCMY-42 has not been described before. On pCMY42_EC8, blaCMY-42 is adjacent 
to the insertion sequence ISEcp1, which was truncated by the insertion of IS1, at upstream and a gene 
encoding outer membrane lipoprotein at downstream (Panel A, Fig.  1). The remaining part of ISEcp1 
was found 24.7-kb further upstream of blaCMY-42 and was also truncated by IS1. After carefully exam-
ining the flanking sequences of ISEcp1 and IS1, it became evident that the complex genetic context of 
blaCMY-42 has been formed by the transposition of ISEcp1 and the insertion of two copies of IS1 followed 
by homologous recombination between the two IS1 (Panel B, Fig. 1) as explained as below. First, both of 
the two IS1 were flanked by a remnant of ISEcp1 and a part of the traB gene, which is involved in plasmid 
conjugation. The two remnants of ISEcp1 form a complete ISEcp1 plus a 9-bp repeat, which abuts the two 
IS1 and is characteristic of the insertion of IS1. Similarly, the two parts of traB make the complete traB 
plus the characteristic 9-bp repeat. It is therefore clear that both ISEcp1 and traB had been interrupted by 
the insertion of IS1 and the subsequent homologous recombination between the two copies of IS1 could 
result in the inversion of the intervening region (Panel B, Fig. 1). Second, it has been proven that a single 
copy of ISEcp1 is able to mobilise its downstream genetic components by using alternative sequences as 
the right-hand inverted repeat (IRR)15. By comparing genetic contexts of blaCMY-2 and its variants avail-
able in GenBank using BLAST, the same 4 kb element comprising ISEcp1, blaCMY, blc (encoding an out-
ermembrane lipoprotein) and sugE (encoding a quaternary ammonium compound-resistance protein) 
has been found on different plasmids but with varied abutting sequences. This element is bounded by 
a 14 bp sequence (AACCAGAAAGTCGA) at one end, which shows some similarity with the left-hand 
inverted repeat (IRL) of ISEcp1 (Panel B, Fig. 1) and might have served as the alternative IRR (IRR2) for 
ISEcp1 to mobilise blaCMY to different locations. Indeed, when we put the two remnants of ISEcp1 back 
together, we found that the finQ gene (the transcriptional inhibitor of plasmid transfer) has been inter-
rupted by the ISEcp1-blaCMY-42-IRR2 region with the presence of 5-bp direct target repeats (DR), which 
characterises the insertion of ISEcp1 (Panel B, Fig.  1). This confirms that the mobilisation of blaCMY-42 
has been mediated by ISEcp1 by misidentifying its IRR.
In strain WCHEC13-8, blaNDM-1 was able to be transferred to E. coli strain J53, suggesting that pNDM1_
EC8 was a self-transmissible plasmid. None of the other resistance genes listed above except blaSHV-12 
were co-transferred with blaNDM-1. PCR-based replicon typing (PBRT) failed to assign pNDM1_EC8 to 
a replicon type as all replicon typing PCR reactions were negative. pNDM1_EC8 was an IncX3 plasmid 
and IncX3 has not been integrated into the PBRT scheme. pNDM1_EC8 is identical to pNDM-HF727 
(GenBank accession number KF976405), an IncX3 plasmid carrying blaNDM-1 from an Enterobacter clo-
acae strain in China9.
IncX3 plasmids are narrow-host-range plasmids of Enterobacteriaceae16. A few IncX3 plasmids car-
rying ESBL genes (blaSHV-11 or blaSHV-12) and/or carbapenemase genes (blaKPC-2, blaNDM-1 or blaNDM-5) 
from various species of Enterobacteriaceae in several countries have been completely sequenced9,17–21. 
In particular, IncX3 plasmids carrying blaNDM-1 and blaSHV-12 have been identified in various species of 
the Enterobacteriaceae at multiple locations in China. The completely-sequenced IncX3 plasmids except 
pKP13d are almost identical in their backbone sequences with less than 9 single nucleotide variations 
between any two plasmids (Fig.  2). The remarkable similarity between IncX3 plasmids suggests that a 
common IncX3 plasmid has spread to different continents, acquired the carbapenemase gene that is 
prevalent locally, e.g. blaKPC-2 in USA and blaNDM-1 in China, and then were transformed as a vehicle 
mediating the interspecies spread of carbapenemase genes in local settings.
IncX3 plasmids carrying blaNDM-1 and blaSHV-12 have also been found in strains causing an out-
break in China22. IncX3 plasmids carrying blaNDM-1 and blaSHV-12 have also been found among the 
Enterobacteriaceae in the United Arab Emirates (UAE). Of note, one of the UAE strain was recovered 
two years earlier than the first Chinese strain that harboured an IncX3 plasmid carrying blaNDM-1 and 
blaSHV-12 was isolated. It remains unclear where the exact origin of emergence of IncX3 plasmids carrying 
blaNDM-1 and blaSHV-12 is. More studies are warranted to characterise the prevalence of IncX3 plasmids in 
the Enterobacteriaceae and to understand the emergence and spread of IncX3 plasmids23.
The genetic context of blaNDM-1 on pNDM1_EC8 is identical to those on pNDM-HF727 and sev-
eral other IncX3 plasmids from China. In such a context, blaNDM-1 is adjacent to an IS5-interrupted 
IS3000-truncated ISAba125 at upstream and is linked with blaSHV-12 at downstream (Fig. 3). blaSHV-12 is 
flanked by IS26, which could form a composite transposon with the potential to mobilise blaSHV-12 into 
different locations.
Conclusions
An ST3835 E. coli clinical isolate carrying multiple genes, e.g. blaNDM-1, blaCTX-M-15, blaCMY-42 and 
blaSHV-12, which are able to confer resistance to broad-spectrum cephalosporins, was identified in China. 
Carbapenemase gene blaNDM-1 was carried by a self-transmissible IncX3 plasmid in this strain. IncX3 
plasmids may have served as a common vehicle mediating the dissemination of blaNDM among the 
Enterobacteriaceae. The recently-identified plasmid-born AmpC gene blaCMY-42 was in a complex genetic 
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Figure 1. Genetic context of blaCMY-42 and its formation on pCMY42_EC8. Panel A, The context of blaCMY-42. 
Δ and shapes with a forked tail represent truncated genes or insertion sequences. The broken line represents 
a 27.4 kb region between traC and finQ, which is not scaled. The putative alternative IRR (IRR2) of ISEcp1 is 
depicted as a red pole and the alignment of the IRL of ISEcp1 and the IRR2 is shown. ISEcp1 and traB are both 
interrupted into two parts. The 9-bp nucleotide repeats belonging to ISEcp1 are depicted in blue and those of 
traB are in red, while the 5-bp nucleotide repeats belonging to finQ is shown in bold. Panel B, The proposed 
scheme for the formation of the context of blaCMY-42. The ISEcp1-blaCMY-42-IRR2 region (structure 1) is inserted 
into the finQ gene of the traA-trbA region (structure 2) on an IncI1 plasmid and then generates the structure 
3 with the 5-bp characteristic DR (GATAA). Two copies of IS1 (structure 4) are then inserted into traB and 
ISEcp1, respectively, generating the structure 5 with the 9-bp DR (CCGTCAATA for traB and CGTTTGAAG 
for ISEcp1), which is the characteristic of IS1 insertion. The subsequent homologous recombination between 
the two copies of IS1 mediates the inversion (shown by two broken arrows) of the intervening region (grey 
part) and then forms the context of blaCMY-42 on pCMY42_EC8 (structure 6).
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context, which was formed by the transposition of ISEcp1 and the insertion of two copies of IS1 followed 
by homologous recombination between the two IS1.
Material and Methods
Strain and in vitro susceptibility. Strain WCHEC13-8 was a clinical isolate recovered in West China 
Hospital of Sichuan University, Chengdu, China. Species identification and in vitro susceptibility test 
were performed using the Vitek II automated system (bioMerieux, Lyon, France). MICs of imipenem, 
meropenem, amikacin, ceftazidime and ciprofloxacin were also determined using the microdilution 
broth method followed recommendations of the Clinical Laboratory Standards Institute24.
Detection of carbapenemase-encoding genes. The strain was screened for acquired 
carbapenemase-encoding genes blaGES, blaKPC, blaIMP, blaIMI, blaNDM, blaOXA-48 and blaVIM using PCR as 
described previously25-28. The complete coding sequence of blaNDM was amplified with an additional pair 
of primers (NDM-up/NDM-dw)25 and the amplicon was sequenced in both directions using an ABI 
3730xl DNA Analyzer (Applied Biosystems, Foster City, CA, USA) at the Beijing Genomics Institute 
(Beijing, China).
Figure 2. Phylogenetic trees of IncX3 plasmids. The trees are generated using MEGA based on the 
complete sequence of IncX3 plasmids. Panel A, a tree of IncX3 plasmids including pKP13d, which carries 
blaKPC-2 in a K. penumoniae strain from Brazil (GenBank accession number CP003997). pKP13d is distinct 
from other IncX3 plasmids in sequence. Panel B, a higher resolution tree of IncX3 plasmids excluding 
pKP13d. The carbapenemase and ESBL genes, the host species, the locations of recovery and the GenBank 
accession number of each plasmid are shown. For host species, CF refers to Citrobacter freundii, EC to E. 
coli, ECL to E. cloacae, KP to K. pneumoniae and RP to Raoultella planticola. The plasmid carrying blaNDM-1 
identified in this study is identical to pNDM-HF727, which is underlined. The GenBank accession number 
of pNDM5_021517 is not available.
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Genome sequencing and analysis. Genomic DNA of strain WCHEC13-8 was prepared using 
QIAamp DNA Mini Kit (Qiagen, Hilden, Germany) and was subjected to whole genome sequencing 
with a ca. 140 × coverage using the Hiseq 2500 Sequencer (Illumina, San Diego, CA, USA) following the 
manufacturer’s protocol at the Beijing Genomics Institute. Reads were assembled to contigs using the 
Spades program29. The Prokka program30 was employed for annotating the genomic sequence. To iden-
tify whether this strain had unique genes, its assembled sequence was compared to the complete chro-
mosome sequences of all of the 83 E. coli strains with their complete genome available in GenBank using 
the Gegenees program31. Potential unique genes were called using a stringent threshold of a 0.9 or higher 
score generated by Gegenees and then were confirmed or rejected using the BLAST program (http://
blast.ncbi.nlm.nih.gov) against the 2,159 draft genomes of E. coli (accessed on December 18, 2014) to 
test whether they were absent from the E. coli draft genome database or not. Function of the products 
encoded by unique genes was predicted using both the Protein BLAST and InterProScan (http://www.
ebi.ac.uk/interpro/) programs. The plasmids carrying blaNDM-1, blaCMY-42 or blaCTX-M-15 were completely 
circularised in sequence with intervals between contigs being filled by PCR with primers designed based 
on available sequences and Sanger sequencing.
Strain typing. Phylogenetic group (A, B1, B2 and D) typing was performed as described previously32. 
Strain WCHEC13-8 was assigned to a ST using the assembled genomic sequence to query the seven 
alleles of the multi-locus sequence typing scheme for E. coli (http://mlst.warwick.ac.uk/mlst/dbs/Ecoli)33. 
Clonal complexes were assigned according to the founder ST identified using eBURST.
Mating experiments and plasmid typing. Conjugation experiment was carried out in broth using 
azide-resistant E. coli strain J53 as the recipient. Transconjugants were selected on plates containing 4 
μ g/ml meropenem plus 150 μ g/ml sodium azide. The presence of blaNDM in transconjugants was con-
firmed using PCR and ERIC-PCR was used for further distinguishing transconjugants from the donor 
strain. Plasmid DNA that was prepared from the transconjugant using alkaline lysis was subjected to 
PCR-based replicon typing (PBRT)34. Sequences of IncX3 plasmids were retrieved from GenBank and 
aligned using MEGA (version 6). Maximum likelihood phylogenetic tree was constructed using MEGA 
using backbone sequences. IncI1 plasmid was assigned to ST and the replicon types of the IncF plasmids 
were assigned after querying their sequence against the plasmid MLST databases (http://pubmlst.org/
plasmid/). Plasmids of the same type as pCTXM15_EC8 were identified using concatenated sequence of 
the IncF replicon alleles of pCTXM15_EC8 for BLAST.
S1-PFGE. S1-PFGE was performed to determine the number and size of plasmids carried by strain 
WCHEC13-8 as described previously35. Briefly, agarose plugs containing whole-cell DNA of strain 
WCHEC13-8 were treated with 8 U of S1 nuclease (Fermentas, Thermo Scientific; Waltham, MA, US) 
and the reaction was stopped by adding 0.5 M EDTA (pH 8). PFGE was conducted with a 1% SeaKem 
Gold agarose gel (Lonza, Basal, Switzerland) using a CHEF DRII system (Bio-Rad, Hercules, CA, US) at 
14°C, with a 6-V/cm current and run times of 12 h at switch time of 5 to 40 s followed by 8 h at switch 
time of 3 to 8 s. MidRange I PFG Marker (NEB, Ipswich, MA, US) was used for size estimation.
Nucleotide sequence accession number. Reads and the Whole Genome Shotgun project of WCHEC13-8 
genomic sequence have been deposited into DDBJ/EMBL/GenBank under accession SRR2012643 and 
LCWG00000000, respectively. The sequence of pCMY42_EC8 and pCTXM15_EC8 has been deposited 
into DDBJ/EMBL/GenBank under accession numbers KP789019 and KP789020, respectively.
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